A Lobbying Group Is Freaking Out Over What Trump May Do To Drug Prices

“The sense that this President could make any decision, at any time, for any reason, on any issue is rattling industries in the health care sector and beyond,” an internal memo from the CEO of the Pharmaceutical Care Management Association says.

Read the story here

posted on Feb. 7, 2017, at 1:54 p.m.